Imaging Technology News

GE HealthCare Imaging Viewer Granted FDA Clearance

tim.hodson — Thu, 12 Mar 2026 22:23:55 +0000

tim.hodson Thu, 03/12/2026 - 17:23

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.² This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision.

Studies show that radiologists spend up to 44% of their time on non-interpretive tasks, such as navigating complex interfaces or waiting for images to load—directly impacting productivity and turnaround times.³ Radiologists are looking for solutions that can help them reduce turnaround time and improve their efficiency.

“View is designed to meet radiologists wherever they are—providing secure, high‑performance access to diagnostic imaging through a truly cloud‑native experience,” said Scott Miller, CEO of Solutions for Enterprise Imaging, GE HealthCare. “By removing traditional infrastructure barriers, we’re enabling faster collaboration, greater flexibility, and more streamlined workflows across care teams. View within the Genesis Workspace reflects our commitment to modernizing radiology in ways that support clinicians and, ultimately, improve patient care.”

View is engineered to optimize the radiology workspace by empowering diagnosticians to work from virtually anywhere¹ with full diagnostic confidence. It delivers high‑performance 2D and 3D visualization alongside AI‑enabled tools to support fast, precise clinical decision‑making. In addition, View provides direct access to the full suite of Advanced Visualization applications, enabling seamless, comprehensive analysis within a single workflow.

“This next‑generation viewer will set a new standard—and could offer the ability to complete almost all of a radiologists’ work in a single, streamlined workspace so they can focus on patient care,” said Dr. Laurie Sebastiano.⁴

This product may not be available in all regions, contact your GE HealthCare sales representative for more information.

Visit here to learn more about GE HealthCare’s Genesis solutions.

Anywhere to state wherever internet is available.
Genesis Radiology Workspace consists of View, Enterprise Archive, and Workflow Manager.
www.sciencedirect.com/science/article/abs/pii/S036301882500194X#sec0007
*Dr. Laurie Sebastiano is a compensated member of GE HealthCare’s advisory board. The statements by Dr. Laurie Sebastiano described here are based on their own opinions.

Thursday, March 12, 2026 - 17:23

Study Demonstrates Reliability of Real-Time Imaging Guidance in Robotic Bronchoscopy

tim.hodson — Thu, 12 Mar 2026 16:53:42 +0000

tim.hodson Thu, 03/12/2026 - 11:53

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed journal, Respiratory Medicine. The study reported on the accuracy of three-dimensional targeting during robotic-assisted bronchoscopy (RAB) procedures using embedded imaging technologies, including digital tomosynthesis (DT) and augmented fluoroscopy (AF). Successful tool-in-lesion was subsequently confirmed with cone-beam computed tomography (CBCT). All procedures in the study were performed using Noah Medical's Galaxy System.

"This publication adds to the growing body of evidence proving that we're at an inflection point in lung cancer diagnosis," said Jian Zhang, CEO of Noah Medical. "The MATCH 2 study demonstrates that when you lead by real-time imaging confirmation with robotic navigation, you get a new level of precision that fundamentally changes what was possible for clinicians and their patients. This is exactly the kind of evidence that will define the standard of care going forward."

Accurate biopsy of peripheral lung lesions remains a central challenge in minimally invasive lung cancer diagnosis. The MATCH 2 study evaluated the performance of RAB with embedded DT and integrated AF to achieve tool-in-lesion (TIL) during robotic bronchoscopy procedures. Thirty-one patients with peripheral pulmonary nodules underwent Robotic-Assisted Bronchoscopy using Noah Medical's Galaxy System.

Key findings included:

96.7% overall diagnostic yield under strict definition
96.7% tool-in-lesion confirmation using digital tomosynthesis
96.7% concordance between digital tomosynthesis with augmented fluoroscopy and cone-beam CT (CBCT) confirmation

Peripheral lung nodules are increasingly detected through screening programs and incidental imaging, yet obtaining a definitive diagnosis remains difficult. Traditional bronchoscopic approaches can struggle with navigation and confirmation, particularly for small or hard-to-reach lesions.

By incorporating real-time imaging enhancements and independent confirmation via cone beam CT, the MATCH 2 study provides additional clinical evidence supporting technology-enabled approaches that can improve diagnostic precision in minimally invasive pulmonary procedures.

"Our findings demonstrate that combining robotic navigation with embedded imaging tomosynthesis (DT) can achieve precise three-dimensional targeting of peripheral lung lesions," said Dr. Amit Mahajan, Medical Director at Inova Health System's Interventional Pulmonology and Complex Airway Disease Program and lead author of the study. He continued, "Reliable confirmation of lesion location is critical to improving diagnostic confidence and diagnosing lung cancer at earlier stages. Early diagnosis of lung cancer is our best chance for cure."

The MATCH 2 Study

MATCH 2 was designed to evaluate three-dimensional targeting accuracy during robotic bronchoscopy procedures using integrated imaging modalities. Accuracy was confirmed using cone-beam CT, which provides three-dimensional volumetric lung imaging during procedures.

The study, "The MATCH 2 Study: Robotic Assisted Bronchoscopy with Integrated Imaging with Assessment of Digital Tomosynthesis and Augmented Fluoroscopy: Three-Dimensional Accuracy as Confirmed by Cone Beam Computed Tomography (CBCT)," was authored by Ankit K. Mahajan, M.D., Duy K. Duong, M.D., Johanna Cortes, N.P. and Krish Bhadra, M.D. and is now available online .

To learn more, please visit www.noahmed.com.

Thursday, March 12, 2026 - 11:53

Research Supports the Integral Role of Ultrasound in Treating Carpal Tunnel Syndrome

tim.hodson — Wed, 11 Mar 2026 20:25:24 +0000

tim.hodson Wed, 03/11/2026 - 15:25

March 11, 2026 — Sonex Health and the Institute of Advanced Ultrasound Guided Procedures recently announced the publication of a manuscript in the Journal of Ultrasound Medicine supporting the role of ultrasound-guided carpal tunnel release (UGCTR) for treating carpal tunnel syndrome (CTS), "Sound Judgment: The Role of Ultrasound Across the Continuum of Care for Carpal Tunnel Syndrome."

The review summarizes the evidence supporting the role of ultrasound in diagnosing and managing CTS, including using ultrasound to assist in diagnosing CTS, perform ultrasound-guided injections, and treat patients with UGCTR. The authors concluded that ultrasound offers significant advantages in terms of patient comfort, safety, and resource utilization, and is supported by evidence demonstrating diagnostic accuracy comparable to that of electrodiagnostic studies, improved injection safety and efficacy, and surgical outcomes that match or exceed those of conventional CTR surgical approaches.

Co-authors include a multidisciplinary group of prominent clinicians with ultrasound and UGCTR experience: Dr. Christopher Jobe, Loma Linda University; Dr. Levon Nazarian, University of Pennsylvania; Dr. Brett Kindle, Andrews Institute for Orthopaedics and Sports Medicine; and Dr. John Fowler, University of Pittsburgh Medical Center.

"Ultrasound is now an integral component in the continuum of care for CTS treatment and offers significant advantages for patient comfort and safety," said Dr. Christopher Jobe. "In addition to these clinical benefits, performing office-based UGCTR under local anesthesia is associated with substantial cost savings by avoiding operating room fees, anesthesia services, and prolonged recovery periods. As clinical data reported in peer-reviewed publications continues to demonstrate sustained outcomes, clinical practice guidelines should be updated to ensure ultrasound-guided interventions are readily accessible to patients."

Key conclusions include:

Ultrasound provides clear visualization of the median nerve (MN) and carpal tunnel contents. Ultrasound can also identify anatomic variants which may increase the risk of injury during carpal tunnel procedures.
Evidence supports the use of ultrasound as a first-line diagnostic modality for CTS as an alternative to electrodiagnostic testing when used in conjunction with the clinical evaluation.
A network meta-analysis reported that UGCTR was associated with the highest patient satisfaction and earlier return to work compared to other CTR techniques.
UGCTR provides symptomatic and functional improvements that are comparable to other CTR techniques, including open carpal tunnel release (OCTR) and endoscopic carpal tunnel release (ECTR).
Major complications are "exceedingly rare," likely due to the continuous, real-time visualization and wide field of view achieved during UGCTR.
UGCTR is well-suited for wide awake local anesthesia no tourniquet (WALANT) techniques. Local anesthesia avoids the cost and complications of general anesthesia or sedation and may be particularly advantageous in the elderly, those with comorbidities and those taking anticoagulants.
Cost-utility analyses have demonstrated that UGCTR is less costly and provides greater quality-adjusted life-year improvements than OCTR and ECTR.
These advantages support the use of UGCTR under local anesthesia in the office-based setting by providing a safe, efficient, and cost-effective option for appropriately selected CTS patients.

"We're grateful to the authors for sharing their assessment of ultrasound's critical role in CTS diagnosis and treatment," said Sonex Health Chief Medical Officer and Co-Founder, Dr. Jay Smith. "This independent publication complements a robust and growing number of peer-reviewed studies that report the benefits of UGCTR in more than 2,300 patients and 2,800 hands. Collectively, these publications support the use of UGCTR with balloon dilation as a favorable, minimally invasive surgical option for treating patients suffering from CTS."

Sonex Health was not involved in the conduct of the study, collection, analysis and interpretation of the data, or preparation, review or approval of the manuscript.

Wednesday, March 11, 2026 - 15:25

Brainomix

tim.hodson — Wed, 11 Mar 2026 15:48:37 +0000

tim.hodson Wed, 03/11/2026 - 10:48

Brainomix Deploys AI Imaging Platform Across WVU Health System Network to Support Stroke Care

tim.hodson — Wed, 11 Mar 2026 15:34:29 +0000

tim.hodson Wed, 03/11/2026 - 10:34

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the deployment of its AI imaging platform, Brainomix 360 Stroke, throughout the West Virginia University (WVU) Health System network. All 25 sites across the network now have access to a unified AI solution designed to support consistent diagnostic assessment and timely treatment for stroke.

Brainomix 360 Stroke is a fully automated AI-imaging platform designed for acute stroke assessment. It delivers objective, real-time insights at every stage of the stroke care pathway, supporting faster, more confident treatment decisions. The platform also helps determine whether a patient should be transferred to a specialist center for advanced stroke interventions. By standardizing assessment across diverse care settings, the platform helps reduce variability in imaging interpretation and complements existing telestroke services to support consistent, high-quality stroke care across the network.

"WVU Health is a visionary partner that understands the power of AI to expand access to expert-level stroke care, particularly in time-critical settings," said Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix. "This collaboration demonstrates how health systems can leverage AI imaging technology to enhance clinical decision-making and support a scalable model for delivering high-quality stroke care across complex health systems. We're proud to support WVU Health's commitment to innovation and clinical excellence."

Dr. Muhammad Alvi, professor and medical director of WVU Stroke Program, added, "This partnership represents a transformative step forward in delivering equitable stroke care across our entire health system. By integrating Brainomix's AI technology into our clinical workflow, we're ensuring that every patient, whether they arrive at our flagship academic medical centers or a regional community hospital, receives the same level of expert stroke assessment. This is about breaking down barriers to advanced care and enhancing stroke services for the communities we serve."

Charles J. Barkey, vice president, information technology of Northern Panhandle WVU Medicine Hospitals, said, "WVU Medicine is committed to advancing patient care through technologies that support clinical decision making and improve the patient experience. As part of this effort, we recently implemented Brainomix's AI imaging platform across our network to help reduce time to treatment for potentially critical stroke types, including large-vessel occlusion. These types of technical initiatives reflect our continued focus on improving the patient and clinical journey with technology, which can ultimately improve outcomes of the patient."

To learn more, go to www.brainomix.com

Wednesday, March 11, 2026 - 10:34

Fujifilm Highlights AI-Driven Products That Help Enhance Enterprise Imaging Workflows

tim.hodson — Tue, 10 Mar 2026 16:22:20 +0000

tim.hodson Tue, 03/10/2026 - 11:22

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions are enabling healthcare organizations to enhance workflows for faster patient throughput, reduce administrative burden and support more personalized care at HIMSS 2026 in Las Vegas.

“AI delivers exceptional impact in medical informatics when it’s seamlessly embedded into the clinical workflows,” said Bill Lacy, senior vice president, medical informatics global business, Fujifilm Healthcare Americas Corp. “At HIMSS, we’re spotlighting our secure, AI-powered Synapse enterprise imaging portfolio, and sharing real-world examples on how these solutions are accelerating radiologist interpretation, improving operational efficiency and creating a more sustainable workflow for radiologists - all while keeping patient care at the center of innovation. We are also highlighting our ever-expanding AI activity in Cardiology, Pathology, and non-imaging AI models.”

Fujifilm’s AI-driven medical informatics solutions that will be highlighted at HIMSS 2026, include:

Synapse AI Orchestrator: An open imaging workflow orchestrator that uses an advanced rules engine to seamlessly bring preferred imaging algorithm results directly to Fujifilm’s Synapse Enterprise PACS workflows. Designed for true interoperability, Synapse AI Orchestrator allows healthcare IT staff to deploy and maintain a multitude of AI applications for clinical workflows across the enterprise.
Synapse Worklist Orchestrator: Fujifilm’s flexible, workload balancing and workflow/worklist orchestration solution transforms how studies are assigned, and how images are interpreted. The solution automatically assigns diverse studies from a variety of sites based on unique conditions set by the organization with the option to ensure assignment equity across subspecialists, if desired. Synapse Worklist Orchestrator uses AI powered learning modules and supports complex enterprise workflows with patented assignment algorithms that are tailored to Synapse Enterprise PACS (radiology, cardiology, pathology) readers.

“Given the challenges groups face today—explosive volumes, rampant burnout, and severe staffing shortages—I genuinely cannot fathom how any practice survives without leveraging this type of solution,” said Dr. Mohit Naik, MD, President Hackensack Radiology Group

Additionally at HIMSS for the first time, Fujifilm will be highlighting Synapse One, the company’s comprehensive, tailor-made workflow solution designed for unique outpatient imaging needs, in North America

Additional information on Fujifilm

Tuesday, March 10, 2026 - 11:22

Philips Debuts New CT System

tim.hodson — Mon, 09 Mar 2026 21:29:47 +0000

tim.hodson Mon, 03/09/2026 - 16:29

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the realities of acute and high-demand imaging³.

Healthcare systems worldwide are under unprecedented pressure. Rising patient volumes, increasing clinical complexity and workforce shortages are pushing frontline, high-acuity and high-demand imaging to its limits. Rembra was engineered from the ground up to meet these challenges, bringing together advanced detector technology, ultra-fast scan and reconstruction speeds and streamlined workflows in a system built for speed, consistency and long-term value.

“Rembra is built for the realities that clinicians face every day,” said Dan Xu, Business Leader for Computed Tomography at Philips. “By combining our most advanced detector technology with AI-powered workflows and industry-leading speed, Rembra represents a significant step forward for high-acuity imaging, delivering speed, access and diagnostic confidence when it matters most.”

Speed to Support Timely Clinical Decisions

In emergency, trauma and other high-demand settings, delays in image reconstruction can slow diagnosis and impact outcomes. Rembra addresses this challenge with a reconstruction speed of up to 106 images per second¹. This speed is designed to help radiologists and clinicians access images quickly in stroke, trauma and other urgent cases. It may support smoother workflows and timely clinical decisions in busy emergency departments.

Designed for high-demand environments, Rembra can support 270 exams per day², helping imaging departments manage growing volumes without compromising speed or confidence.

Optimized Patient Positioning

With a 85 cm bore, Rembra is designed to help facilitate patient access and positioning, and may help improve comfort for trauma, bariatric and interventional cases.

Rembra features a 60 cm standard field of view (sFOV) and an 85 cm extended field of view (eFOV), both the largest in their class of frontline radiology CT systems⁴, enabling full anatomical visualization in a single scan. Rembra also features a high-performance patient table with Philips’ best-in-class scan range of up to 2.3 meters and gantry-to-tablespace of 46 cm to support flexible patient positioning.

“In interventional and high acuity settings, precise access and efficient positioning are essential,” said Professor Olivier Rouvière, MD, PhD, Head of Department at Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon). “Rembra’s 85 cm bore supports improved access as well as faster and safer positioning of long needles and instruments in complex procedures.”

Clinical Performance

At the heart of Rembra is Philips’ newest NanoPanel Precise XD, a high-density detector designed from the outset to work hand-in-hand with AI. It delivers high dose-efficiency, high-resolution imaging at the source and is designed to support overall image quality and diagnostic confidence.

The detector offers exceptional in-plane spatial resolution of 23 line pairs per cm, enabling sharp detail and visualization of fine anatomical structures down to 0.25 mm. A 2D anti-scatter grid provides strong scatter rejection to help preserve image clarity in challenging patient types, supporting consistently high image quality across patient sizes and clinical scenarios.

Productivity, Predictability and Long-term Value

Integrated AI-enabled smart workflows can help automate routine steps and simplify certain operations. These features are intended to support workflow efficiency for consistent results.

Built for operations at high-altitude environments up to 5000m, Rembra is engineered for reliability, durability and long-term performance, supporting a system lifetime of up to 20 years with required maintenance and upgrades. Philips’ Tube for Life⁵ service program further enhances cost predictability by covering tube replacement costs for up to 10 years.

Click here to learn more.

Sources

Based on publicly available manufacturer specifications for leading radiology CT systems as of March 2026 on reconstruction speed in this class of scanners and bore size.
Based on a sixteen-hour day, with throughput testing with 203 patient scans/ 12 hours for Rembra with typical radiological profiles and protocols.
Pending 510(k) - not available for sale in the USA
The Extended Field of View (EFOV) of 85 cm is intended solely for use in treatment preparation and the planning/simulation of radiation therapy. It cannot be used for diagnostic purposes. The water equivalent material external contour deviation of body system phantom positioned (partially) outside scan FOV with phantom edge adjacent to bore cover shall be within 1mm in terms of mean Hausdorff distance compared to the true external contour.
Tube for Life guarantee availability varies by country. Please contact your local Philips sales representative for details

Additional information on Philips

Monday, March 9, 2026 - 16:29

FDA Approves GE HealthCare's Next‑Gen Diagnostic Viewer

tim.hodson — Mon, 09 Mar 2026 16:13:39 +0000

tim.hodson Mon, 03/09/2026 - 11:13

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“View is designed to meet radiologists wherever they are — providing secure, high‑performance access to diagnostic imaging through a truly cloud‑native experience,” said Scott Miller, CEO of Solutions for Enterprise Imaging, GE HealthCare. “By removing traditional infrastructure barriers, we’re enabling faster collaboration, greater flexibility, and more streamlined workflows across care teams. View within the Genesis Workspace reflects our commitment to modernizing radiology in ways that support clinicians and, ultimately, improve patient care.”

View is engineered to optimize the radiology workspace by empowering diagnosticians to work from virtually anywhere with full diagnostic confidence. It delivers high‑performance 2D and 3D visualization alongside AI‑enabled tools to support fast, precise clinical decision‑making. In addition, View provides direct access to the full suite of Advanced Visualization applications, enabling seamless, comprehensive analysis within a single workflow.

Click here to learn more about GE HealthCare’s Genesis solutions.

Anywhere to state wherever internet is available.
Genesis Radiology Workspace consists of View, Enterprise Archive, and Workflow Manager.
3https://www.sciencedirect.com/science/article/abs/pii/S036301882500194X#sec0007
Dr. Laurie Sebastiano is a compensated member of GE HealthCare’s advisory board. The statements by Dr. Laurie Sebastiano described here are based on their own opinions.

This product may not be available in all regions, contact your GE HealthCare sales representative for more information.

Addoitional GE HealthCare Information

Monday, March 9, 2026 - 11:13

A New Standard of Care

tim.hodson — Mon, 09 Mar 2026 14:55:26 +0000

tim.hodson Mon, 03/09/2026 - 09:55

GE Healthcare to Highlight AI-powered, Cloud-first Software Solutions at HIMSS

tim.hodson — Fri, 06 Mar 2026 17:49:56 +0000

tim.hodson Fri, 03/06/2026 - 11:49

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las Vegas, GE HealthCare will spotlight meaningful technology transforming how healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound and patient care technologies.

The healthcare industry continues to confront worsening workforce gaps with projections showing multi‑specialty shortages through 2038 and demand projected to outpace supply in multiple health professions, placing sustained pressure on health systems to deliver care more efficiently.¹ To address today’s challenges and support clinicians tomorrow, GE HealthCare solutions are designed to reduce clinical and operational complexities and help providers quickly turn data into insights to help streamline workflows.

“The future of healthcare depends on how effectively we remove complexity and empower clinicians,” said Scott Miller, CEO, Solutions for Enterprise Imaging (SEI), GE HealthCare. “By anticipating what healthcare teams need next, we’re accelerating cloud and AI‑enabled solutions that help them work smarter, make faster, better‑informed decisions, and deliver more connected, accessible care.”

GE HealthCare continues to lead the industry in artificial intelligence (AI) innovation, topping an FDA list of AI-enabled medical device authorizations, with 115 authorizations to date.² At HIMSS 2026, GE HealthCare will exhibit several solutions pushing the boundaries of innovation.

GE HealthCare is continuing to work across the industry to enable real-time data exchange between medical devices by joining the Health Level Seven International (HL7) Caliper FHIR Accelerator as a founding member. Caliper is an implementation community focused on improving how data from medical and personal health devices is exchanged, integrated, and used across healthcare systems. The coalition’s work will enable consistent integration of high‑fidelity device data into EHRs, analytics and AI‑enabled applications to support clinical decision‑making and care delivery across settings and devices.

Key innovations:

CareIntellect for Perinatal³, is a cloud-first application that delivers clear, actionable insights to help clinicians access data efficiently, supporting time management at the point of care. Designed for native EMR accessibility, CareIntellect for Perinatal supports clinicians by integrating high fidelity monitor data with information from disparate data sources on a single screen, to support clinicians when monitoring status, annotating clinical events, searching historical data, and remotely monitoring.
Command Center is AI-enabled software that helps hospitals and health systems manage patient flow, streamline operations, and make data-driven decisions in real-time. Used by nearly 500 hospitals and medical facilities globally, Command Center is a comprehensive, customizable solution supporting care management at every stage, from daily patient care and staff onboarding to cross-department coordination and proactive issue resolution across the hospital system.
Genesis Radiology Workspace⁴ is a next-generation solution designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision. Genesis View is a powerful new viewer designed to be a fast diagnostic, zero-footprint viewer – streamlining radiology workflows with the intent to enhance patient care while being fully accessible from any location.
Imaging 360 unlocks the full potential of imaging operations. Powered by AI, this solution delivers a unified view that helps streamline radiology fleet management, connect staff remotely⁵, optimize staff allocation and support consistent quality of care.
Verisound Digital and AI Ultrasound Solutions, a portfolio of connectivity, collaboration, and AI-driven tools — designed to enhance efficiency and consistency in imaging, reduce scan and read times, improve reproducibility and enable collaboration across care teams.
- Verisound Collab is a dynamic collaboration hub driving real-time mentoring and engagement between peers and experts, before, during, and after an ultrasound exam to share expertise, provide support during complex exams, and elevate care delivery.⁶
- Verisound Fleet empowers clinical and healthcare technology teams to remotely view, back up, and deploy device configurations and manage probes.
- ViewPoint is an ultrasound workflow solution built for scalability, reliability and interoperability aiming to solve challenges that stem from complex and expanding operations. The solution integrates advanced automation technology to create reports with findings, provide access to patient scan data from anywhere and simplify IT administration and maintenance.
Vscan Air Enterprise Solutions, suite of digital tools for Vscan Air, help address workflow challenges, offer improved security and privacy while improving the ability to simplify operations and control fleet of handheld ultrasound systems.

Health Resources and Services Administration (HRSA) National Center for Health Workforce Analysis (NCHWA) Report: Health Workforce Projections, 2023–2038. https://data.hrsa.gov/topics/health-workforce/nchwa/workforce-projections.
U.S. Food and Drug Administration. “Artificial Intelligence-Enabled Medical Devices.” https://www.fda.gov/medical-devices/software-medical-device-samd/artifi….
CareIntellect Perinatal formerly Mural Perinatal Surveillance, a 510(k)-cleared device in the U.S. is the product name. CareIntellect for Perinatal may appear in descriptive content. Not all features and functionality are available in all markets. Product configurations are subject to change without notice. Availability is dependent on regional regulatory authorizations.
Genesis Radiology Workspace consists of Genesis View, Workflow Manager, Enterprise Archive, App Orchestrator. Genesis View is not available for sale in the United States. This product cannot be placed on the market or put into service until it has been made to comply with CE marking. Genesis Radiology Workspace is not yet commercially available for USA and UK.
Remote scanning, training and collaboration can be fulfilled by either nCommand™ Lite by IONIC Health or Digital Expert Access with Remote Scanning for MR by GE HealthCare. Consult your sales representative for availabilities in your region.
Not for diagnostic use

Friday, March 6, 2026 - 11:49